In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
May 7th, 2010 | 27 | No |
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 2.43 | 6.82 | -17.12 | 2 | 7 | 0 | 100 | 387.871 | 7 | ↓ |
Hi High (pH 8-9.5) | 2.62 | 4.47 | -42.12 | 1 | 7 | -1 | 106 | 386.863 | 7 | ↓ |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
CATB-1-E | Cathepsin B (cluster #1 Of 6), Eukaryotic | Eukaryotes | 5012 | 0.27 | Binding ≤ 10μM |
CATK-1-E | Cathepsin K (cluster #1 Of 3), Eukaryotic | Eukaryotes | 1995 | 0.30 | Binding ≤ 10μM |
CATL1-1-E | Cathepsin L (cluster #1 Of 5), Eukaryotic | Eukaryotes | 79 | 0.37 | Binding ≤ 10μM |
CATL2-1-E | Cathepsin L2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 501 | 0.33 | Binding ≤ 10μM |
CATS-2-E | Cathepsin S (cluster #2 Of 2), Eukaryotic | Eukaryotes | 794 | 0.32 | Binding ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
CATL1_HUMAN | P07711 | Cathepsin L, Human | 79.4328235 | 0.37 | Binding ≤ 1μM |
CATL2_HUMAN | O60911 | Cathepsin L2, Human | 501.187234 | 0.33 | Binding ≤ 1μM |
CATS_HUMAN | P25774 | Cathepsin S, Human | 794.328235 | 0.32 | Binding ≤ 1μM |
CATB_HUMAN | P07858 | Cathepsin B, Human | 5011.87234 | 0.27 | Binding ≤ 10μM |
CATK_HUMAN | P43235 | Cathepsin K, Human | 1995.26231 | 0.30 | Binding ≤ 10μM |
CATL1_HUMAN | P07711 | Cathepsin L, Human | 79.4328235 | 0.37 | Binding ≤ 10μM |
CATL2_HUMAN | O60911 | Cathepsin L2, Human | 501.187234 | 0.33 | Binding ≤ 10μM |
CATS_HUMAN | P25774 | Cathepsin S, Human | 794.328235 | 0.32 | Binding ≤ 10μM |
Description | Species |
---|---|
Activation of Matrix Metalloproteinases | |
Assembly of collagen fibrils and other multimeric structures | |
Collagen degradation | |
Degradation of the extracellular matrix | |
Endosomal/Vacuolar pathway | |
MHC class II antigen presentation | |
Trafficking and processing of endosomal TLR |